Trading Report: Today, Recent Investment Analysts’ Ratings Changes for The Medicines (MDCO)

Today, Recent Investment Analysts’ Ratings Changes for The Medicines (MDCO)

The Medicines (NASDAQ: MDCO) has recently received a number of price target changes and ratings updates:

Shares of The Medicines Co. (NASDAQ:MDCO) traded down 1.33% during midday trading on Friday, reaching $37.23. The company’s stock had a trading volume of 322,810 shares. The firm’s market cap is $2.61 billion. The stock’s 50 day moving average price is $35.56 and its 200 day moving average price is $36.64. The Medicines Co. has a one year low of $27.50 and a one year high of $43.00.

The Medicines (NASDAQ:MDCO) last released its quarterly earnings data on Wednesday, October 26th. The company reported ($0.64) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($1.30) by $0.66. The business earned $37.60 million during the quarter, compared to analyst estimates of $37.26 million. The Medicines had a negative return on equity of 35.07% and a negative net margin of 96.44%. The company’s revenue was down 34.3% on a year-over-year basis. During the same quarter last year, the business posted ($0.82) EPS. Analysts predict that The Medicines Co. will post ($1.41) earnings per share for the current year.

Related posts

Leave a Comment